SEC Form D · filed January 13, 2021
KEMPHARM, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Timothy J. Sangiovanni · Celebration, FLExecR. L. Clifton · Celebration, FLExecTravis C. Mickle · Celebration, FLExec · Director · PromoterDavid S. Tierney · Celebration, FLDirectorJoseph B. Saluri · Celebration, FLDirectorSven L. Guenther · Celebration, FLExecRichard W. Pascoe · Celebration, FLDirectorMatthew R. Plooster · Celebration, FLDirectorStuart N. Ballard · London, United KingdomDirectorTodd Hixon · Reston, VAExecScott Johnson · Reston, VAExec · Director · PromoterSims Lansing · New York, NYDirectorStephen Sarsfield · Las Vegas, NVExecKenneth D. Cron · New York, NYExecCormac Sheehan · New York, NYDirectorKatherine Lewis · Las Vegas, NVDirectorAngela P. Ciampa · BOSTON, MADirectorScott B. Garfield · BOSTON, MADirectorVipon B. Ghai · BOSTON, MAExecScott B. Mcfetridge · BOSTON, MAExecBrian R. Albert · BOSTON, MAExec · Director · PromoterPaul A. Fishbin · BOSTON, MADirectorJoshua A. Liebow · BOSTON, MADirectorAdrienne Lerner · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗